Loading...
Freedom of Information (FOI) NHS Lothian | Our Organisation

Request and Response Register

NOTE: 100 recent requests are displayed below. Use search to find older requests.
Freedom of Information Request Reference: 10020
Date Received: 23/04/2025
Summary:
Could you please give me a list of all the brands, models, and ages of all the continuous renal replacement therapy devices in the health board that are used in Critical Care?
Date of Response: 23/05/2025
View Response: 10020.pdf
Freedom of Information Request Reference: 10019
Date Received: 23/04/2025
Summary:
1. How much money did the NHS spend on providing the following services in the calendar years 2022, 2023, 2024 and 2025 to date: a. Homeopathy b. Reiki c. Energy Therapy d. Chakra Balancing e. Emotional Freedom Techniques f. Acupuncture 2. How many homeopathic products were prescribed by GPs and other doctors working for or under contract to the NHS in the calendar years 2022, 2023, 2024 and 2025 to date.
Date of Response: 12/05/2025
View Response: 10019.pdf
Freedom of Information Request Reference: 10017
Date Received: 23/04/2025
Summary:
Which departments use Elastomeric Infusion Devices? i.e. Oncology, Haematology, Urology, ENT, Surgery, Orthopaedics, OPAT, Paediatrics, Virtual wards, Palliative Care, other Which brand(s) of Elastomeric Infusion Devices do you use? i.e. Baxter Intermate, Baxter Infusor, Vygon Accufuser, Adriamed Easyflow, Nipro Surefuser+, B. Braun Easypump II, Leventon Dosi-Fuser, other Does your trust purchase pre-filled Elastomeric Infusion Devices from commercial providers? If yes, How many do you buy pre-filled per year? Which drugs do you buy pre-filled? Does your trust fill Elastomeric Infusion Devices in your pharmacy aseptic unit? If yes, How many do you fill in your pharmacy aseptic unit per year? Which drugs do you fill in your pharmacy aseptic unit? Does your trust fill Elastomeric Infusion Devices in patient’s homes/outpatient clinic/community setting or similar environment? If yes, How many do you fill in patient’s homes/outpatient clinic/community setting per year? Which drugs do you fill in patient’s homes/outpatient clinic/community setting?
Date of Response: 12/05/2025
View Response: 10017.pdf
Freedom of Information Request Reference: 10016
Date Received: 22/04/2025
Summary:
1. A list of all -cides used by the Board. This is inclusive of, but not limited to: any and all avicides, biocides, fungicides, herbicides, insecticides, pesticides, and rodenticides. 2. The annual cost and volume of purchase of each of these -cides, broken down by -cide, from January 2014 to December 2024. Please list this on a spreadsheet (CSV), broken down by: 1. -Cide 2. Product Name 3. Volume Purchased 4. Price Paid 5. Purchase Date 3. A list of each of these -cides' use, by volume. Through this I am trying to ascertain whether the purchased volume is matched by the used volume, so if there is a record of expired or unused -cides too, that would be ideal. Please add this to the above CSV as an additional column, also on an annual basis over the same time period. Please list volume in either litres or kilograms, whichever is more appropriate. 4. Only if available and easily accessible, the location and purpose of each specific -cide’s use. For the former, this may be classified by: location grouping, address, coordinate, or otherwise.
Date of Response: 21/05/2025
View Response: 10016.pdf
Freedom of Information Request Reference: 10014
Date Received: 22/04/2025
Summary:
1. What technology platform does the Trust currently use to support its Direct Engagement (DE) model for the medical locum workforce? 2. What is the name of the platform provider? 3. What is the cost of the platform expressed as a percentage fee or pence per hour? 4. What staffing groups does the Trust include in its Direct Engagement (DE) model (e.g., medical, AHPs, clinical, non-clinical)? 5. What is the current uptake of the DE model within the Trust, specifically as a percentage or proportion of the total locum workforce?
Date of Response: 09/05/2025
View Response: 10014.pdf
Freedom of Information Request Reference: 10012
Date Received: 22/04/2025
Summary:
Q1. How many total patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Dravet Syndrome (DS) Q2. Of total DS patients, how many have been treated with Epidyolex (Cannabidiol) in the last 12 months? Q3. Of total DS patients, how many have been treated with Fintepla (Fenfluramine) in the last 12 months? Q4. How many total patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Lennox-Gasteau Syndrome (LGS) Q5. Of total LGS patients, how many have been treated with Epidyolex (Cannabidiol) in the last 12 months? Q6. Of total LGS patients, how many have been treated with Fintepla (Fenfluramine) in the last 12 months? Q7. How many adult (aged 18+) patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Dravet Syndrome (DS) Q8. How many adult (aged 18+) patients has the trust seen within the latest 24 months of available data (for any reason), with a recorded diagnosis of Lennox-Gasteau Syndrome (LGS)
Date of Response: 16/05/2025
View Response: 10012.pdf
Freedom of Information Request Reference: 10011
Date Received: 17/04/2025
Summary:
I'm interested to know how many Cardiopulmonary Exercise Testing Systems (CPET/CPEX) are in use throughout the trust. For each system I'd like to know: 1. The number of current devices in use 2. Manufacturer and type of device 3. Which hospitals are they in 4. Which departments are they in 5. Date of installation
Date of Response: 16/05/2025
View Response: 10011.pdf
Freedom of Information Request Reference: 10010
Date Received: 22/04/2025
Summary:
1. Within your health board could you specify the name and location of each of your emergency departments, minor injury units, walk in centres and urgent treatment centres. For each of your individual Emergency Departments, Walk in Centres, Minor Injury Units or Urgent Treatment centre could you please answer the following questions: 2. Which of the following options best describes the social prescribing provision in your Emergency Department, Walk-In-Centre, Minor Injuries Unit or Urgent Treatment Centre? a) We have an active social prescribing service b) We previously had a social prescribing service, but it is not active currently c) We are currently developing a social prescribing service d) We have never had a social prescribing service 3. What date did your social prescribing service start? 4. What date did your social prescribing service end? If you have selected option c or d no further information is required. 5. Which of the following factors does/did your social prescribing service support with? a) Housing and homelessness b) Violence reduction c) Alcohol and drugs d) Social isolation and loneliness e) Mental health f) Severe and multiple disadvantage g) High intensity/ high frequency service use h) Employment and training i) Youth specific interventions j) Early years interventions k) Domestic abuse l) Independent living m) Other – please could you tell us 6. How many patients are/were referred to your social prescribing service on average each month? 7. How is/was your social prescribing service funded? 8. How many social prescribers (Whole Time Equivelent) are employed in your emergency department?
Date of Response: 16/05/2025
View Response: 10010.pdf
Freedom of Information Request Reference: 10009
Date Received: 22/04/2025
Summary:
1. A list of all contracts awarded to third-party healthcare providers for subcontracted works/contracts within the past 12 months. 2. The nature and scope of the subcontracted works for each contract. 3. The total value of each contract. 4. The names of the third-party providers awarded the contracts.
Date of Response: 09/05/2025
View Response: 10009.pdf
Freedom of Information Request Reference: 10008
Date Received: 22/04/2025
Summary:
This FOI request therefore concerns the period between November 2024 and today. 1. ‎How many (headcount) of your employees work in these areas: Health Visitors, audiologists, speech and language therapists, Ear Nose and Throat staff, paediatricians working with deaf babies and children, newborn hearing screening, technician or support worker in any of these areas. 2. Of these staff in (1) above, how many have so far taken this new NHS online module? GIRFEC E-learning module, Informed level. 3. Of these staff in (1) above, how many have so far taken this NHS online module? GIRFEC E-learning module, Skilled level. 4. Of these staff in (1) above, how many have so far taken both of these NHS online courses about Getting It Right for Every Child? 5. How will you evaluate the effectiveness of these courses on the day-to-day practice of your staff in working more closely and effectively with education and other services in the interests of the child?
Date of Response: 21/05/2025
View Response: 10008.pdf
Freedom of Information Request Reference: 10007
Date Received: 22/04/2025
Summary:
1. Please can you confirm the emergency departments (ED) within your trust - both their name and address. 2. In each of your EDs are your registered nurses (RN) allowed to give intravenous (IV) morphine. 3. In each of your EDs are your registered nurses allowed to give intravenous (IV) diamorphine. 4. In each of your EDs are your registered nurses allowed to give intravenous (IV) fentanyl. 5. If RNs are allowed to give either IV Morphine, IV Diamorphine or IV Fentanyl - did they undertake a specific drug training package? 6. If so which drug, was it for? Would you be able to share this training package. 7. If they are not allowed to give IV Morphine, IV Diamorphine or IV Fentanyl who is allowed to give each of the drugs? 8. For each of the drugs are there any specific areas where the drugs can only be given with in the ED?
Date of Response: 16/05/2025
View Response: 10007.pdf
Freedom of Information Request Reference: 10006
Date Received: 22/04/2025
Summary:
We would like to make a request under the FOI Act for information spanning the financial years ending 2021 to 2025. Please provide the following information relating to the Trust move towards Digital Pathology for its Histology Diagnostic Services 1. How many WSI (whole slide imaging) slide scanners does the Trust have installed in its Pathology Departments to digitise Histopathology slides 2. Please state in which year each of the scanners was purchased & Installed 3. Please state if the method of acquisition was Capital Purchase, Lease or acquired using a Managed Service Contract. 4. If possible, please state the total capital amount invested by the Trust in their scanners for the periods requested 5. Please state the brand and model of each scanner 6. Please state which Image Manage System (IMS) is used with the scanners 7. Please state what percentage of diagnostic cases were digitised in the last full year 8. If not 100% were specific subspecialities digitised? 9. Do the Trust employed Histopathologists report from a Trust site or do they report from a remote site (e.g. home) or a hybrid model. Please state numbers 10. Is there any plan to purchase and add to the number of scanners already installed in the Trust in the current and next financial years
Date of Response: 21/05/2025
View Response: 10006.pdf
Freedom of Information Request Reference: 10004
Date Received: 17/04/2025
Summary:
Do NHS Lothian have single sex facilities for example toilets, changing rooms and single sex wards on hospital sites and / or GP surgeries? When providing medical care to an individual whose gender self-identity differs from the biological sex noted on their medical record, do NHS Lothian permit access to single sex hospital or GP surgery facilities in accordance with the individual's biological sex or their preferred gender self-identification? If an individual whose biological sex differs from their gender self-identity requests medical care from NHS staff of the opposite biological sex to themselves, do NHS Lothian accede to their request including where it involves intimate care? What policy document and / or guidelines to NHS Lothian defer to in relation to the provision of single sex facilities for individuals whose biological sex is the opposite to that of their gender self-identity?
Date of Response: 19/05/2025
View Response: 10004.pdf
Freedom of Information Request Reference: 10003
Date Received: 17/04/2025
Summary:
This is an information request relating to NHS Trusts buying and supplying Paracetamol and ibuprofen. Please include the following information for the financial years 2022/23, 2023/24 and 2024/25: •The total number of individual patients to whom paracetamol and ibuprofen were prescribed by your Trust annually. •The total amount spent by your Trust on supplying prescribed paracetamol and Ibuprofen in each of those financial years. •If available, a breakdown of the form in which paracetamol was prescribed (e.g., tablets, capsules, liquid suspension, etc.) and associated costs for each form. •What are the specific conditions which qualify a patient to be prescribed paracetamol or ibuprofen? Or what is your general policy for qualifying a prescription for paracetamol or ibuprofen?
Date of Response: 19/05/2025
View Response: 10003.pdf
Freedom of Information Request Reference: 10002
Date Received: 17/04/2025
Summary:
From 1st January 2025 to 31st March please provide a breakdown of: • Total trust spend with framework agencies for locum AHP/HSS staffing. Please provide a further breakdown for locum AHP/HSS staffing by: • Spend per band • Spend per specialty • Spend per agency name From 1st January 2025 to 31st March please provide a breakdown of: • Total trust spend with off-framework agencies for locum AHP/HSS staffing. Please provide a further breakdown for locum AHP/HSS staffing by: • Spend per band • Spend per specialty • Spend per agency name From 1st January 2025 to 31st March please provide a breakdown of: • Total trust spend with the internal trust bank or associated external provider for locum AHP/HSS staffing Please provide a further breakdown for locum AHP/HSS staffing by: • Spend per grade • Spend per specialty • Spend per internal or associated external provider Please confirm your allocated budget for agency locum AHP/HSS staffing for the period 1st January 2025 to 31st March
Date of Response: 19/05/2025
View Response: 10002.pdf
Freedom of Information Request Reference: 10001
Date Received: 17/04/2025
Summary:
Q1. Over the past 6 months, how many adult multiple myeloma [MM] patients have you treated? If you refer your multiple myeloma patients to another centre, please state which. Q2. Of the multiple myeloma patients treated over the past 6 months, how many were treated with the following: • Any other systemic anti-cancer therapy • Belantamab Mafodotin [Blenrep] • Belantamab Mafodotin [Blenrep] with bortezomib and dexamethasone • Belantamab Mafodotin [Blenrep] with pomalidomide and dexamethasone • Bortezomib [Velcade] monotherapy or with dexamethasone • Bortezomib [Velcade], Melphalan/Cyclophosphamide and prednisolone/dexamethasone (VMp or VCd) • Bortezomib, thalidomide and dexamethasone [VTD] • Carfilzomib [Kyprolis] and dexamethasone • Carfilzomib [Kyprolis], Lenalidomide [Revlmid] and dexamethasone • Daratamumab [Darzalex] with Lenalidomide [Revlimid] and dexamethasone • Daratumumab [Darzalex] monotherapy • Daratumumab [Darzalex], Bortezomib [Velcade] and dexamethasone (known as DVd or DBd) • Daratumumab [Darzalex], Bortezomib [Velcade], thalidomide and dexamethasone (known as Dara-VTd) • Elranatamab • Idecabtagene vicleucel [Abecma] • Isatuximab [Sarclisa], Pomalidomide [Imnovid] and dexamethasone (known as IsaPd) • Ixazomib [Ninlaro], Lenalidomide [Revlmid] and dexamethasone (known as IRd) • Lenalidomide [Revlimid] and dexamethasone • Lenalidomide [Revlmid] monotherapy • Panobinostat in combination with Bortezomib and Dezamethasone • Pomalidomide [Imnovid] and dexamethasone • Selinexor and dexamethasone • Selinexor, Bortexomiv [Velcade] and dexamethasone • Talquetamab • Teclistamab [Tecvayli]
Date of Response: 09/05/2025
View Response: 10001.pdf
Freedom of Information Request Reference: 10000
Date Received: 17/04/2025
Summary:
Can you please provide me with the following information with regards your stoma care services. 1. A copy of your stoma department’s annual report produced by the stoma care team 2. Do you have a local stoma forum in place? 3. If you do have a local stoma forum how often does it meet and please detail who are the members of the forum
Date of Response: 23/05/2025
View Response: 10000.pdf
Freedom of Information Request Reference: 9999
Date Received: 16/04/2025
Summary:
1. Policy on Fertility Preservation: o Does your ICB have a specific policy regarding fertility preservation (e.g., egg or embryo freezing) for patients with endometriosis prior to surgical intervention for ovarian endometriomas/ endometriotic cysts? 2. Clinical Criteria for Funding: o Are there set clinical criteria that must be met for patients with endometriosis to receive NHS funding for fertility preservation? For example, do these criteria include:  Age restrictions?  Requirement for patients to be undergoing surgery for bilateral endometriomas or other specific endometriosis-related surgeries?  A previous history of surgery for endometriosis?  A specific Anti-Müllerian Hormone (AMH) cut-off value? 3. Scope of Funding: o If funding is available, is it typically provided for one cycle of egg/embryo freezing, or are additional cycles potentially funded if the patient responds poorly to the initial cycle? 4. Second or Further Cycles: o In the case of an unexpectedly poor response to the initial funded cycle, is there any possibility of additional funding being granted for a second or further cycle of egg/embryo freezing? 5. Statistics on Funding Applications: o How many patients with endometriosis have been granted NHS funding for fertility preservation prior to surgery in the last two years? o How many funding applications for fertility preservation for patients with endometriosis have been made and subsequently declined during this same period? 6. Please provide the information in an electronic format. If any of the requested information is not available, or if it exceeds the cost limit under the FOI Act, please provide any partial information or guidance on how to refine the request.
Date of Response: 16/05/2025
View Response: 9999.pdf
Freedom of Information Request Reference: 9997
Date Received: 16/04/2025
Summary:
I would like to know the annual cost to NHS Lothian of the Tableau dashboard. I would like a breakdown of the cost by 1 Lothian Health employees’ salaries who manage data 2 The cost of the soft wear. Is there a separate licence fee per Practice?
Date of Response: 09/05/2025
View Response: 9997.pdf
Freedom of Information Request Reference: 9995
Date Received: 16/04/2025
Summary:
1. What framework are you associated with for sterile service agency supply? 2. Who is responsible for agency usage on framework and off framework in the Sterile Services/Decontamination department at all hospitals associated with the Trust 3. Please can you provide the contact number and email address for the manager(s) in questions 1 and 2 4. Have you used on-framework agency staff between March 2024 and March 2025 in Sterile Services? 5. How much was your on-Framework agency spend for Sterile Services between March 2024 and March 2025? 6. Have you used off-framework agency staff between March 2024 and March 2025 in Sterile Services? 7. How much was your Off-Framework agency spend for Sterile Services between March 2024 and March 2025? 8. Do you currently outsource your Sterile Services/Decontamination department, if yes, who do you outsource it to?
Date of Response: 16/05/2025
View Response: 9995.pdf
Freedom of Information Request Reference: 9994
Date Received: 16/04/2025
Summary:
I would like to submit a request for information under the Freedom of Information (Scotland) Act 2002 regarding cases of food poisoning due to incorrect identification or inappropriate preparation of wild food. Please provide the relevant information for the period between 1 April 2020 and the most recent date for which data is available. Please could you provide the following: a. A yearly breakdown of the number of cases of food poisoning due to incorrect identification or inappropriate preparation of wild food. b. The type of wild food that caused the food poisoning (for example: fungi, plant, berries, etc…). Please include the specific species if known. c. The symptoms experienced by the patient and the recovery time (for example: overnight stay or discharged within a couple hours) d. The location where this food was picked.
Date of Response: 07/05/2025
View Response: 9994.pdf
Freedom of Information Request Reference: 9993
Date Received: 15/04/2025
Summary:
Please can you provide the following information in relation to your expenditure over the last financial year (2024/25) of Medical Locum Doctors via off-framework suppliers: 1. Number of hours filled? 2. Broken down by grade/specialty? 3. Off-framework agencies used during this period including the total spend for each agency? 4. Highest off-framework charge rate (including detail of grade/specialty)? 5. Average off-framework charge rates per grade/specialty (if available)? 6. Contact details for the member of staff / department responsible for on-boarding Doctor agencies?
Date of Response: 07/05/2025
View Response: 9993.pdf
Freedom of Information Request Reference: 9992
Date Received: 15/04/2025
Summary:
We are seeking the policy and procedures in place for Clinical Forensic Nurses who attend patients in police custody. Specifically, we are seeking the policy and procedure that was in place in September 2021.
Date of Response: 09/05/2025
View Response: 9992.pdf
Freedom of Information Request Reference: 9991
Date Received: 15/04/2025
Summary:
1. What the health board's current estimate is for the number of people living with asthma within its boundary. 2. How and when was this number reached? i.e. using GP data, prescription data, primary and secondary care referrals.
Date of Response: 02/05/2025
View Response: 9991.pdf
Freedom of Information Request Reference: 9990
Date Received: 15/04/2025
Summary:
It is my understanding that your health board holds data on your Health Visitors, procedures and standards. As such, can I request the following information for each calendar year from 2019 to 2025 (most recent): 1. The number of health visitor visits that have been cancelled? 2. The number of health visitor visits that have been cancelled due to non clinical capacity reasons? 3. The number of health visitor visits that have been changed from being in person to over the phone instead? 4. The number of families assigned to each health visitor? 5. The percentage of children who have received all 11 of the policy assigned visits as part of the Universal Health Visiting Pathway? 6. The number of families that have not had all 11 home visits due to staffing issues?
Date of Response: 16/05/2025
View Response: 9990.pdf
Freedom of Information Request Reference: 9925
Date Received: 31/03/2025
Summary:
Can I please get the last five years of this information? The recorded number of incorrect medication doses given to anyone admitted to Royal Hospital for Children with a breakdown along with the medication and incorrect dose given, as well as the correct dose that should have been given. I would like this information to include ages of the patient involved in each reported case.
Date of Response: 23/05/2025
View Response: 9925.pdf
Freedom of Information Request Reference: 9919
Date Received: 27/03/2025
Summary:
I am writing to request information under the Freedom of Information Act 2000 regarding support services available to haemato-oncology and leukaemia patients at your NHS health board. Support Workers: 1. Do you provide cancer support workers, or similar roles (e.g., navigators, cancer care co-ordinators) to your haemato-oncology patients? o If yes: a. How many do you employ, and what is the Full-Time Equivalent (FTE)? b. What is their average caseload? c. How many are employed by a third party (e.g., charity), and what is the FTE? d. What is their caseload? 2. What percentage of your leukaemia patients have accessed their services? Counselling Services: 3. Do you provide counselling or psychological support for leukaemia patients through: a. Mental health professionals? b. Digital platforms (e.g., apps)? c. Any other relevant services? 4. How many staff do you employ to provide cancer emotional support, and what is the FTE? 5. What are: a. The average, b. The minimum, and c. The maximum waiting times from referral to first appointment or first access point for emotional support services? 6. How do patients get referred to these services (e.g., clinical nurse specialist, GP, self-referral)? 7. Are there any limits on the number of sessions or amount of time cancer patients can access counselling? 8. What percentage of all cancer patients you care for access emotional support in-house? 9. What percentage of leukaemia patients you care for access emotional support? Welfare Support: 10. Do you offer welfare advice or practical support (e.g., benefits, financial help, transport) to: a. All cancer patients? b. Leukaemia patients? 11. How do patients access this support, and how is the information shared with them? 12. How many staff and FTE staff are responsible for delivering welfare support services? 13. How many leukaemia patients accessed welfare support in the past 12 months? What percentage of the total leukaemia patients you care for does this represent?
Date of Response: 21/05/2025
View Response: 9919.pdf
Freedom of Information Request Reference: 9888
Date Received: 19/03/2025
Summary:
I am looking for evidence showing who paid for 'hard maintenance' works to the Stockbridge Health Centre building from 1975-2025. Hard maintenance includes: any electrical and plumbing work, ceiling repairs, lighting, installation fixtures and fittings (sinks, cupboards), lift maintenance, heating, soil pipes, drains etc. It does NOT include cleaning, telecoms, utilities bills and rent. Information in the form of letters, emails, invoices, receipts, spreadsheets, capital funding projects would be helpful.
Date of Response: 16/05/2025
View Response: 9888.pdf
Freedom of Information Request Reference: 9783
Date Received: 24/02/2025
Summary:
Relating to The Audit 1. How many patients and/or parents of patients of LPA did you write to in relation to the findings and recommendations in The Audit. 2. Into which cohort, scale and treatment category (as described above) those patients and/or parents fell. 3. Whether you only wrote to patients and/or families whose records were reviewed as part of the The Audit. 4. What, if any, exercise you undertook to extrapolate from the Audit how many patients of the 22,900 treated between 2009 and 2018 by LPA fell into each cohort, scale, and treatment category. 5. Accordingly, what consideration, if any, was given to your obligation under the Duty of Candour in respect of all 22,900 patients and/or their parents treated between 2009 and 2018. 6. The extent to which you considered and took a decision upon which patients and/or parents of patients you were required to write to in terms of the cohorts, scale, and treatment category; and the patients whose records were reviewed and those patients whose records were not reviewed by The Audit. 7. How many patients and/or the parents whose records were not reviewed as part of the Audit to whom did you write. Relating to the Extended Cohort Audit 1. In addition to the patients/parents contacted in light of The Audit (and covered above by questions 1-7 above) how many patients and/or parents of patients of LPA did you write to in relation to the findings and recommendations in The Extended Cohort Audit. 2. What, if any, exercise you undertook to extrapolate from the Audit and The Extended Cohort Audit how many patients treated by LPA may have been affected by sub-optimal treatment. 3. Accordingly, what consideration, if any, was given to your obligation under the Duty of Candour in respect of all of such patients and/or their parents.
Date of Response: 23/05/2025
View Response: 9783.pdf
Freedom of Information Request Reference: 9989
Date Received: 15/04/2025
Summary:
1. Please confirm the policy of NHS Lothian regarding eligibility for NHS bank health care support worker roles? 2. Are these roles reserved for final year student nurses? 3. In principle and subject to all applicable checks, would NHS Lothian accept a nurse with previous experience, undertaking a return to practice course, to join the staff bank at Band 3 or 4? 4. What are the reasons behind NHS Lothian policies on eligibility for bank staff roles? 5. Has there been any change to eligibility policy in recent years given workforce shortages and the pressing need to retain experienced staff?
Date of Response: 15/05/2025
View Response: 9989.pdf
Freedom of Information Request Reference: 9988
Date Received: 15/04/2025
Summary:
• What is the current policy in your health board area for patients to request same-sex care, particularly in situations involving intimate examinations or procedures? Are patients able to request same-sex care from their GP or healthcare professional (same biological sex), particularly when they are undergoing intimate exams? • When was this policy first enforced in your health board? • Can you provide a copy of this policy.
Date of Response: 06/05/2025
View Response: 9988.pdf
Freedom of Information Request Reference: 9987
Date Received: 09/04/2025
Summary:
- Does your health board have a policy on mixed-sex wards, and if so, when was it implemented? - Which specific wards does this policy apply to (e.g., outpatient endoscopy, surgical, or medical wards)? - Could you provide a copy of your health board’s policy on mixed-sex wards?
Date of Response: 29/04/2025
View Response: 9987.pdf
Freedom of Information Request Reference: 9986
Date Received: 11/04/2025
Summary:
I request all and any information held by your authority in relation to the introduction on 31 March 2025 of the "New Triage" arrangements at Edinburgh prison in terms of: 1) any impact assessment undertaken prior to the introduction of the arrangements; 2) any consultation with patient groups; 3) any consultation with SPS management/TUS groups; 4) any other consultation or discussion undertaken.
Date of Response: 08/05/2025
View Response: 9986.pdf
Freedom of Information Request Reference: 9985
Date Received: 14/04/2025
Summary:
For each financial year between 2020 and 2025 (or the latest available date), please provide yearly figures for the below: 1. The number of employment tribunal claims bought by nurses, trainee nurses and nursing associates against the trust. [example answer: 2020 – 0, 2021 – 2, 2022 – 0, 2023 – 1, 2024 – 1] 2. The outcome from each claim [E.g. withdrawn, won, lost- e.g: In 2020, 1 was in favour of the claimant, 2 were in favour of the respondent, 1 was discontinued/settled out of court] 3. How many cases each year led to an employment tribunal ruling the organisation must pay costs to the claimant, and how much was paid [example answer: 2020 – 1 case, £0 paid; 2021 – 2 cases, £12,000 paid; 2022 – 3 cases, £0 paid; 2023 – 0 cases, £0 paid, 2024 – 3 cases, £0 paid] 4. If possible, please break down each claim by type [e.g. public interest disclosure, unfair dismissal, discrimination]
Date of Response: 09/05/2025
View Response: 9985.pdf
Freedom of Information Request Reference: 9984
Date Received: 14/04/2025
Summary:
1. How many MRI scanners does the NHS in Scotland have? 2. How many are suitable for Patients with a high BMI and are obese and cannot fit in an MRI scanner? 3. How many MRI scanners does Lothian NHS have? 4. How many are suitable (in Lothian NHS) for obese patients with a high BMI? 5. How many patients, who are deemed obese, and cannot fit in an MRI scanner, have been sent to a private institution, such as SPIRE, to have an MRI scan? 6. How many obese patients, who cannot fit in the MRI scanner at the ERI, has the Department of General Surgery sent to either a private institution or to the zoo (any zoo) where the MRI scanners are apparently able to scan larger patients and animals?
Date of Response: 12/05/2025
View Response: 9984.pdf
Freedom of Information Request Reference: 9983
Date Received: 14/04/2025
Summary:
I would like to ask what harm reduction policies you have in place for transgender/non-binary people who are taking hormone replacement therapy without a prescription or medical supervision.
Date of Response: 08/05/2025
View Response: 9983.pdf
Freedom of Information Request Reference: 9982
Date Received: 11/04/2025
Summary:
Q1. How many patients have been treated (for any condition) in the last 4 months with: •Benralizumab •Dupilumab •Omalizumab •Reslizumab •Mepolizumab •Tezepelumab Q2. How many patients have been treated in the last 4 months by the Respiratory Medicine department ONLY with: •Dupilumab •Omalizumab
Date of Response: 08/05/2025
View Response: 9982.pdf
Freedom of Information Request Reference: 9981
Date Received: 11/04/2025
Summary:
Could you please supply us with 1) STAFFING FOR YOUR NHS CHRONIC PAIN CLINICS (which deal mainly with outpatients) Number/s FTE hours per week Pain Consultant Pain psychologist Nurse Physiotherapist Occupational therapist Administration 2) What is the annual budget from your Board for chronic pain specialist clinic work, physical and mental health. 3) Number of referrals of patients in your last complete year, physical and mental health.
Date of Response: 15/05/2025
View Response: 9981.pdf
Freedom of Information Request Reference: 9979
Date Received: 11/04/2025
Summary:
I wish to make a Freedom of Information Request for the number of Clinical Psychologists the organisation as. Both full time & part time.
Date of Response: 05/05/2025
View Response: 9979.pdf
Freedom of Information Request Reference: 9978
Date Received: 11/04/2025
Summary:
1. Has a company called Saltire Roofing & Building ltd ever done any work or been sub contracted out to your health board? 2. When did this company first start doing work on your behalf? 3. How many jobs has this company done for you? 4. How much money have you paid this company? 5. Did this company start working for you by publicly tendering for contracts or were they brought in through the back door? 6. Did the owner of the company Steven Mcintosh Edwards ever work for your health board as an employee? 7. How long should a company be trading before they are sub contracted out to your health board? 8. Would your health board sub contract work out to an ex employee? 9. If an ex employee claimed to have broke there leg at work, was then compensated financially by your health board, then set up a private building firm with the money, would you ever consider sub contracting work out to that said persons company? 10. Would you allow managers to socialise with the same sub contractors at local country clubs paid for by the private company of the profits they made from your health board? 11. If managers were doing this would you class that as receiving gifts or taking back handers?
Date of Response: 13/05/2025
View Response: 9978.pdf
Freedom of Information Request Reference: 9977
Date Received: 10/04/2025
Summary:
Can you please provide your trust’s IT spend for the following financial year: FY 2023-24: Please include in your IT spend calculation the cost of your IT staff, Software, Services, Hardware, Communication equipment and Other IT spend for the requested financial year. Also, can you please clarify if you still use ICE by Clinisys as your Order Communications System? If yes, can you please provide the expiration date? Also, can you please clarify if you still use iLab by Dedalus as your Pathology System? If yes, can you please provide the expiration date? Can you please clarify if you still use Oracle by Oracle as your HR System? If yes, can you please provide the expiration date?
Date of Response: 08/05/2025
View Response: 9977.pdf
Freedom of Information Request Reference: 9976
Date Received: 10/04/2025
Summary:
I am writing to request the following information under the Freedom of Information (Scotland) Act 2002, relating to births within your health board area from April 2024 to April 2025 (inclusive or up to the latest available data): 1. Total number of births, month by month. 2. Breakdown of birth methods, month by month: o Forceps deliveries o Vacuum (ventouse) deliveries o Episiotomies o Water births o Home births 3. Number of caesarean sections, broken down by: o Elective caesareans o Emergency caesareans 4. Number of inductions, month by month.
Date of Response: 06/05/2025
View Response: 9976.pdf
Freedom of Information Request Reference: 9975
Date Received: 10/04/2025
Summary:
A. The amount the NHS spent on translation services in the calendar years 2022, 2023, 2024 and 2025 to date. B. Provide a list of the languages that the NHS provided translation services for in the calendar year 2024.
Date of Response: 09/05/2025
View Response: 9975.pdf
Freedom of Information Request Reference: 9974
Date Received: 09/04/2025
Summary:
Please provide the following information in relation to your eHealth/Digital team: 1. Team Structure: Please provide your current team structure (excluding individual names), outlining role titles and the number of full-time equivalent (FTE) posts for each. Additionally, please confirm your total salary budget for digital services for the past 3 years. If any posts also have responsibility for medical records, please separate this information accordingly. 2. Senior Digital Leadership: Please detail the most senior digital post within your Board and its position within the senior Board Management Team. 3. Digital Clinical Leadership: Please outline the clinical digital leadership arrangements within your Board, including the number of posts and associated funding for the past 3 years. Where applicable, please confirm if these posts are also included in your response to Question 1. 4. Revenue Budget – Supplies and Services: Please provide the total revenue budget for digital supplies and services for each of the past 3 years. Summary totals are sufficient. 5. Capital Expenditure: Please provide details of capital expenditure on digital services over the past 3 years. 6. Scottish Government Strategic Funding: Please provide details of any Scottish Government “Strategy/Strategic” funding received over the past 3 years, including a breakdown on expenditure between staffing and supplies/services. Please confirm whether these figures are included in your response to Question 3. 7. Digital Strategy: Please provide a copy of your most up-to-date Digital Strategy.
Date of Response: 15/05/2025
View Response: 9974.pdf
Freedom of Information Request Reference: 9973
Date Received: 10/04/2025
Summary:
1. Does your Integrated Care System (ICS) or any NHS organisation within your ICS have specialist midwives dedicated to supporting women who use substances during the perinatal period? • If so, please provide any documentation available for these services, such as referral guidelines, service protocols, or links to relevant webpages or online resources. 2. Are there any other dedicated services within your ICS area that provide care to women who use or are in treatment for substances during the perinatal period? • Please provide details on the service, including: 1. Who leads the service and which professionals are involved in delivering the care. 2. Whether this service is a partnership between: i. NHS ii. Third sector organisations iii. Local authority iv. Other organisations 3. If applicable, whether the service involves a manualised intervention, is an outreach service, or has a specific location. 4. Whether the service is provided by a national organisation, or any other relevant details.
Date of Response: 02/05/2025
View Response: 9973.pdf
Freedom of Information Request Reference: 9972
Date Received: 10/04/2025
Summary:
Question1: the Lothians NHS board are responsible for the provision of healthcare, including mental health and psychiatry services, within retrospective HMP prisons in their board area. Please provide the expected and actual wait times for a prisoner within any given HMP establishment, specifically for a ADHD Assessment. I would be satisfied with a general answer, such as the range of wait times(shortest to longest) as opposed to specific prisons, however I ask that you provide the data for the last 3 years. Question 2: How many persons have been diagnosed with ADHD whilst serving a custodial sentence within any hmp establishment in the Lothian board. Please provide data for the last 3 years.
Date of Response: 07/05/2025
View Response: 9972.pdf
Freedom of Information Request Reference: 9971
Date Received: 10/04/2025
Summary:
I am writing to request an internal review of Lothian NHS Board's handling of my FOI request 'Surgical referrals from Chalmers GIC'. In particular, I am concerned with the response to my question 4: "If [there has been a pause or restriction on patients of Chalmers GIC being referred for surgery at any point since 1 January 2024], please provide all communications, minutes, agendas and policy documents which include mention of the pause or restriction, from a time period of six months before the start of the pause or restriction to the present day." The response I received applied an exemption under Section 25 of the Freedom of Information (Scotland) Act 2002, because the information I requested had already been disclosed in previous FOI requests from other people, three of which are linked in the response. However, on review of the linked FOI responses, none of them appear to contain copies of the requested documents. I would therefore request a review of your response, as the information I requested is not available at the provided links, so the exemption appears to have been incorrectly applied.
Date of Response: 08/05/2025
View Response: 9971.pdf
Freedom of Information Request Reference: 9970
Date Received: 09/04/2025
Summary:
I'd like to request data under FOI about how many teeangers are treated in your A&E departments for knife wounds, in order to assess whether that number is going up or down in recent years. Are you able to tell me if data is recorded in that much detail? If so, I'd like the figures for ages 12-19 years old over the past 5 years.
Date of Response: 13/05/2025
View Response: 9970.pdf
Freedom of Information Request Reference: 9969
Date Received: 09/04/2025
Summary:
Please can I request the below information on the utilisation of Insourcing for the following period 01/01/2025-31/03/2025 • Total spend during the period for Insourcing for the below specialties: • Neurology • Neurophysiology • Dermatology • Gastroenterology • Endoscopy • Cardiology • Respiratory • Orthodontics / Dental • OMFS • ENT • Rheumatology • Gynaecology • Please break the spend down by insourcing company • Please confirm if there was a budget for insourcing for the specialties outlined during the same period • What was the service type relating to the specialties outlined, for example, outpatient, diagnostic or theatres. • Was it a fully managed service or Team provision • Please can you confirm the Frameworks utilised for each specialty • Please confirm any direct awards or mini competitions which are being utilised for each specialty • Total procedures completed by insourcing companies for the specialties outlined during the same period
Date of Response: 30/04/2025
View Response: 9969-1.pdf
Freedom of Information Request Reference: 9968
Date Received: 09/04/2025
Summary:
I would be grateful if you could please answer the following question with regards to cancer treatment: In the last 12 months, how many unique patients in your Health Board have been treated privately for the following ICD-10 codes? A) C61 Malignant neoplasm of prostate B) C16.0 Malignant neoplasm of the gastroesophageal Junction
Date of Response: 30/04/2025
View Response: 9968.pdf
Freedom of Information Request Reference: 9967
Date Received: 09/04/2025
Summary:
I am requesting the following information in respect of: • Diabetes: - SMBG test strips - Pen needles and safety pen needles - CGM - Continuous Glucose monitoring systems • Continence - Leg Bags - Drainage/night bags - ISC catheters - Foley catheters - Incontinence sheaths For each area: 1. The name(s) and direct contact email address(es) and direct telephone numbers of the person(s) who are responsible for the formulary 2. The date of the next review of your formulary 3. Details of how you intend to review your formulary (include process, timelines) 4. Details if part of a local partnership arrangement for formulary review. Please provide the contact’s name, email address and telephone number for the person with responsibility where a partnership arrangement is in place.
Date of Response: 30/04/2025
View Response: 9967.pdf
Freedom of Information Request Reference: 9966
Date Received: 04/09/2025
Summary:
The numbers of patients who underwent surgery to repair an abdominal aortic aneurysm at the Edinburgh Royal Infirmary in years 2019, 2020 and 2021.
Date of Response: 02/05/2025
View Response: 9966.pdf
Freedom of Information Request Reference: 9965
Date Received: 09/04/2025
Summary:
In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.3ppm but less than or equal to 0.4ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.4ppm but less than or equal to 0.5ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.5ppm but less than or equal to 0.6ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.6ppm but less than or equal to 0.7ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.7ppm but less than or equal to 0.8ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.8ppm but less than or equal to 0.9ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 0.9ppm but less than or equal to 1ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 1ppm but less than or equal to 1.5ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that are greater than 1.5ppm but less than or equal to 2ppm in the Trust’s Histopathology Department? In the past 12 months, on how many separate occasions have formaldehyde levels been recorded that exceed 2ppm in the Trust’s Histopathology Department?
Date of Response: 07/05/2025
View Response: 9965.pdf
Freedom of Information Request Reference: 9964
Date Received: 08/04/2025
Summary:
Q1. How many patients has your Trust treated (for any medical condition) in the past 3 months with the following drugs: • Alprolix • BeneFIX • Haemate P • Idelvion • Refixia • Rixubis • Veyvondi • Voncento • Wilate • Willfact Q2. How many patients have been treated in the past 3 months with: • Marstacimab for Haemophilia B ONLY • Gene therapy for Haemophilia B ONLY • Desmopressin for Von Willebrand Disease ONLY • Tranexamic Acid for Von Willebrand Disease ONLY Q3. Of the patients that were treated with Veyvondi in the past 3 months, how many patients received treatment: • Prophylactically • During surgery • On demand to treat bleeding episodes Q4. Of the patients that were treated with Voncento in the past 3 months, how many patients received treatment: • Prophylactically • During surgery • On demand to treat bleeding episodes Q5. How many patients are registered with your trust for the following diseases: • Haemophilia B • Von Willebrand Disease • Von Willebrand Disease - paediatric patients (age 17 or under)
Date of Response: 02/05/2025
View Response: 9964.pdf
Freedom of Information Request Reference: 9961
Date Received: 08/04/2025
Summary:
The question concerns the recent advertisement and appointment of a Consultant in Emergency Medicine at the Royal Infirmary of Edinburgh. 1. How many doctors applied for this post? 2. Of those that applied how many were shortlisted? How many were interviewed? 3. Of the doctors that applied for this post, how many declared a financial interest in Alphamed Scotland or any other company. What is the process for declaring financial conflicts of interest at the time of application? 4. With regards to writing the job description, requesting approval for the post, approval, advertising, shortlisting, interviewing and appointing a candidate, how many doctors were involved at each stage? Please include any stages that I have omitted. Please include medical management. What were their grades? 5. Of the above, how many have completed a financial conflict of interest declaration or similar by the time of the appointment to this post? How many have subsequently made such a declaration? 6. Of the above, how many are or have been employees or shareholders or otherwise have had any relationship with Alphamed Scotland? 7. What are the NHS Lothian policies regarding financial conflicts of interests as applied to recruitment? What are the responsibilites of a member of an appointing panel? 8. To what extent was the person specification for this job tailored to Dr Waterston's CV? 9. Please disclose the person specification for this job and for the previous three consultant in emergency medicine jobs at the Royal Infirmary of Edinburgh 10. To what extent was the person specification different for this job as compared to the previous three? 11. To what extent did the narrow person specification for this job prevent other Emergency Medicine doctors from being eligible? 12. Please disclose any email or other correspondance related to writing the job description, requesting approval for the post, advertising, shortlisting, interviewing and appointing a candidate, please include any stages that I have omitted. If parts of correspondance are redacted, please disclose as much as possible. 13. Please disclose any email or other correspondance by any of the above identified doctors related to the company Alphamed Scotland 14. Please disclose any email or other correspondence regarding this job advert and Dr Waterson, prior to the job being advertised 15. Is there any other information held by NHS Lothian that would be helpful in answering the overarching question above 16. Has the financial conflict of interest in this case been reported to any external authority?
Date of Response: 30/04/2025
View Response: 9961.pdf
Freedom of Information Request Reference: 9960
Date Received: 07/04/2025
Summary:
The number of patients managed by your Hospital at Home services during 2024? How many whole time equivalent staff members employed in your hospital at home services on December 2nd 2024? How many whole time equivalent band 3 or 4 support workers employed in your hospital at home services on December 2nd 2024? How many whole time equivalent band 5 or 6 nurses employed in your hospital at home services on December 2nd 2024? How many advanced clinical/nurse practitioners employed in your hospital at home services on December 2nd 2024? How many recorded days of sickness absence for staff members in hospital at home during 2024? The number of hospital at home staff members with 28 consecutive calendar days of sickness absence?
Date of Response: 13/05/2025
View Response: 9960.pdf
Freedom of Information Request Reference: 9959
Date Received: 03/04/2025
Summary:
In accordance with the Environmental Information Regulations 2004 please provide: a. copies of any current menus for the Trust’s hospitals; b. a copy of any current food and drink strategy prepared pursuant to the National Standards; Page 7 of 7 c. any other documents evidencing your consideration of (i) the National Standards, (ii) the 2014 Regs, (iii) the Climate Change Duty or the (iv) the NHS Constitution Duty as they relate to either food service generally or to the service of processed red meat in particular.
Date of Response: 30/04/2025
View Response: 9959.pdf
Freedom of Information Request Reference: 9958
Date Received: 07/04/2025
Summary:
Q1. Within your trust, how many patients currently have a diagnosis for: •Fabry(-Anderson) disease (ICD10 code E75.21) •Gaucher disease (ICD10 code E75.22) •Pompe disease (ICD10 Code E74.02) •Pompe disease (ICD10 Code E74.02) infantile onset (patients diagnosed before age 1) •Hunter syndrome (MPS II) (ICD10 code E76.1) Q2. Of the patients above, how many patients have been newly diagnosed within the past 3 months for: •Fabry(-Anderson) disease (ICD10 code E75.21) •Gaucher disease (ICD10 code E75.22) •Pompe disease (ICD10 Code E74.02) •Pompe disease (ICD10 Code E74.02) infantile onset (patients diagnosed before age 1) •Hunter syndrome (MPS II) (ICD10 code E76.1) Q3. How many patients have been treated in the last 3 months with the following products: •Replagal (agalsidase alfa) •Fabrazyme (agalsidase beta) •Galafold (migalastat) •Elfabrio (pegunigalsidase alfa) •VPRIV (velaglucerase alfa) •Cerezyme (imiglucerase) •Cerdelga (eliglustat) •Zavesca (miglustat) •Myozyme (alglucosidase alfa) •Nexviadyme (avalglucosidase alfa) •AT-GAA (cipaglucosidase alfa/miglustat) Q4. Do you participate in any clinical trials for Fabry(-Anderson) disease? If so, can you please provide the name of each trial along with the number of patients taking part? Q5. Do you participate in any clinical trials for Gaucher disease? If so, can you please provide the name of each trial along with the number of patients taking part?
Date of Response: 05/05/2025
View Response: 9958.pdf
Freedom of Information Request Reference: 9957
Date Received: 07/04/2025
Summary:
1. Since the legislation was legally commenced on 1 October 2023, how has NHS Lothian paid due regard to community benefit in non-emergency patient contracts, and the extent to which such contracts will improve economic, social or environmental wellbeing, to comply with its duty under Part 10, Section 120 of the Transport (Scotland) Act 2019? 2. Since the legislation was legally commenced on 1 October 2023, how has NHS Lothian worked with bodies which provide community transport services in its area in providing non-emergency patient transport services to comply with its duty under Part 10, Section 121, Subsection 1 of the Transport (Scotland) Act 2019? 3. Since the legislation was legally commenced on 1 October 2023, how has NHS Lothian reported on: • the steps it has taken to comply with these duties under the Transport (Scotland) Act 2019; • the extent to which non-emergency patient transport services in its area have been effective and cost-effective; and, • further action it proposes to take to comply with these duties? 4. In each of the last 5 years, how much did NHS Lothian spend on non-emergency patient transport? 5. In each of the last 5 years, how much did NHS Lothian spend with private taxi firms on non-emergency patient transport? 6. In each of the last 5 years, how much did NHS Lothian spend with non-profit organisations which provide community transport services on non-emergency patient transport?
Date of Response: 30/04/2025
View Response: 9957.pdf
Freedom of Information Request Reference: 9956
Date Received: 07/04/2025
Summary:
Please can you provide the below information: In the period 1st January 2025 to 31st March 2025 please provide a breakdown of: Total trust spend with framework agencies for locum nurses Please provide a further breakdown for locum nurses by: Spend per band Spend per specialty Spend per agency name In the period 1st January 2025 to 31st March 2025 please provide a breakdown of: Total trust spend with off framework agencies for locum nurses Please provide a further breakdown for locum nurses by: Spend per band Spend per specialty Spend per agency name In the period 1st January 2025 to 31st March 2025 please provide a breakdown of: Total trust spend with the internal trust bank or associated external provider for locum nurses Please provide a further breakdown for locum nurses by: Spend per band Spend per specialty Spend per agency name Please confirm the total number of nursing shifts booked during this period for all agency nursing only, no bank staff nursing to be included (1st January 2025 to 31st March 2025) Please confirm the total number of nursing shifts booked above NHSE capped rates during this period for all agency nursing only, no bank staff nursing to be included (1st January 2025 to 31st March 2025)
Date of Response: 28/04/2025
View Response: 9956.pdf
Freedom of Information Request Reference: 9955
Date Received: 07/04/2025
Summary:
The below questions relate to oversees/foreign patients who were given NHS treatment while visiting Scotland that they were required to pay for. Please can you tell me: • The number of patients who were not entitled to free treatment on the health service in each of the last five financial years (2019/20, 2020/21, 2022/23, 2023/24, 2024/25). Please provide a breakdown of where the patients were from (i.e. the country they were visiting Scotland from). • The number of patients with outstanding debt following free treatment in each of the last five financial years (2019/20, 2020/21, 2022/23, 2023/24, 2024/25). • The total outstanding debt as a result of free treatment given to oversees patients in each of the last five financial years (2019/20, 2020/21, 2022/23, 2023/24, 2024/25). • The total portion written off as bad debt in each of the years? • The departments most commonly used by overseas visitors? Please provide a breakdown of where the patient is originally from.
Date of Response: 07/05/2025
View Response: 9955.pdf
Freedom of Information Request Reference: 9954
Date Received: 04/04/2025
Summary:
Q1. How many haemophilia A patients are registered with your centre, and how many of these patients are classified as exhibiting mild, moderate, or severe disease. Q2. In the last three months, how many Haemophilia A patients, including on-demand patients, have been treated with the following products? • Altuvoct • Advate • Adynovi • Elocta • Esperoct • Factor Eight Inhibitor Bypass Activity (FEIBA) • Hemlibra (Emicizumab) - Standalone • Hemlibra (Emicizumab) in combination with any Factor VIII • NovoEight • NovoSeven RT • Nuwiq • Obizur • Refacto AF • Any other products • Hympavzi (Marstacimab) • CEVENFACTA Q3. For patients treated with Advate in the last three months, please provide: • The number of haemophilia A patients treated prophylactically • The number of haemophilia A patients treated for any other reason (e.g. surgery, on-demand, breakthrough bleeds) Q4. In the last three months, how many patients were treated with the following products for severe Haemophila A ONLY? • Altuvoct • Advate • Adynovi • Elocta • Esperoct • Factor Eight Inhibitor Bypass Activity (FEIBA) • Hemlibra (Emicizumab) - Standalone • Hemlibra (Emicizumab) in combination with any Factor VIII • NovoEight • NovoSeven RT • Nuwiq • Obizur • Refacto AF • Any other products • Hympavzi (Marstacimab) • CEVENFACTA
Date of Response: 28/04/2025
View Response: 9954.pdf
Freedom of Information Request Reference: 9953
Date Received: 04/04/2025
Summary:
As such, can you provide the following for the financial years 2019/20, 2020/21, 2021/22, 2022/23, 2023/24 and 2024/25 (most recent): • How much has been spent on external management consultants • The name of the company/individual commissioned, and the length of the contract • Information on the project
Date of Response: 29/04/2025
View Response: 9953.pdf
Freedom of Information Request Reference: 9952
Date Received: 04/04/2025
Summary:
For each of the following hormone therapies used to treat prostate cancer, please provide the number of patients treated at your Trust between 01 January and 31 December (by years 2023 and 2024). For each therapy, broken down the data into the following categories: 1. Total Number of Patients Treated for ICD-10 C61 / M1-M1c (metastatic) 2. Number of Patients for Whom Hormone Therapy Was Initiated for ICD-10 C61 / M1-M1c (metastatic) 3. Number of Patients for Whom Hormone Therapy Was Continued; ICD-10 C61 / M1-M1c (metastatic) 4. Number of patients for whom docetaxel was initiated for ICD-10 C61 / M1-M1c (localised & metastatic) The hormone therapies of interest are: a. ADT alone b. Abiraterone (Zytiga) in combination with any ADT c. Abiraterone (Zytiga) – no ADT d. Enzalutamide (Xtandi) in combination with any ADT e. Enzalutamide (Xtandi) – no ADT f. Apalutamide (Erleada) in combination with any ADT g. Darolutamide (Nubeqa) in combination with any ADT h. Darolutamide (Nubeqa) in combination with any ADT with docetaxel i. Docetaxel in combination with any ADT Total number of patients in each year, for each therapy for whom:  Hormone therapy was initiated  Hormone therapy was continued  Docetaxel was initiated
Date of Response: 02/05/2025
View Response: 9952.pdf
Freedom of Information Request Reference: 9951
Date Received: 04/04/2025
Summary:
1. The number of children who have been treated for malnutrition in NHS Lothian over the last five years. 2. The number of children who have been referred to a specialist for malnutrition in NHS Lothian over the last five years.
Date of Response: 12/05/2025
View Response: 9951.pdf
Freedom of Information Request Reference: 9948
Date Received: 04/04/2025
Summary:
How many stillbirth, neonatal, extended perinatal, post-neonatal and infant deaths occurred per 1,000 total births in your health board area in each of the last four full financial years. If possible please then breakdown these figures, again for each of the last four full financial years, by each category (stillbirth, neonatal, extended perinatal, post-neonatal and infant deaths). How many stillbirth, neonatal, extended perinatal, post-neonatal and infant deaths occurred per 1,000 total births in the maternity units/wards run by your health board in each of the last four full financial years. In the response please can you state the name of the maternity unit/ward, the year and its mortality rate encompassing all of the above categories of death.
Date of Response: 12/05/2025
View Response: 9948.pdf
Freedom of Information Request Reference: 9947
Date Received: 04/04/2025
Summary:
Please can I have a copy of all final Significant Adverse Event Review (SAERs) reports produced for SAERs commissioned by your health board in each of the last four full financial years which relate to stillbirth, neonatal , extended perinatal, post- neonatal and infant deaths.
Date of Response: 12/05/2025
View Response: 9947.pdf
Freedom of Information Request Reference: 9946
Date Received: 04/04/2025
Summary:
In total, how many Significant Adverse Event Review (SAERs) were commissioned by your health board in each of the last four full financial years which relate to stillbirth, neonatal , extended perinatal, post- neonatal and infant deaths. Please then breakdown these figures, again for each of the last four full financial years, by each category (stillbirth, neonatal, extended perinatal, post-neonatal and infant deaths).
Date of Response: 12/05/2025
View Response: 9946.pdf
Freedom of Information Request Reference: 9944
Date Received: 03/04/2025
Summary:
For each financial year from 2019/20 to 2024/25 (most recent) 1. The median completed wait (in days) for gynaecology treatment, broken down by (a) inpatient, and (b) outpatient appointment. 2. The longest completed wait (in days) for gynaecology treatment, broken down by (a) inpatient, and (b) outpatient appointment. 3. The median ongoing wait (in days) for gynaecology treatment, broken down by (a) inpatient, and (b) outpatient appointment. 4. The longest ongoing wait (in days) for gynaecology treatment, broken down by (a) inpatient, and (b) outpatient appointment.
Date of Response: 30/04/2025
View Response: 9944.pdf
Freedom of Information Request Reference: 9937
Date Received: 02/04/2025
Summary:
- Does your health board have a policy on mixed-sex wards, and if so, when was it implemented? - Which specific wards does this policy apply to (e.g., outpatient endoscopy, surgical, or medical wards)? - Could you provide a copy of your health board’s policy on mixed-sex wards?
Date of Response: 29/04/2025
View Response: 9937.pdf
Freedom of Information Request Reference: 9936
Date Received: 02/04/2025
Summary:
If NHS Lothian has concluded its land acquisition deal with Enterprise Scotland for the plot marked for the new eye pavilion. If they have concluded, what was the outcome. If still ongoing: an update on the latest stage of negotiations alongside any relevant correspondence regarding the acquisition deal.
Date of Response: 25/04/2025
View Response: 9936.pdf
Freedom of Information Request Reference: 9935
Date Received: 01/04/2025
Summary:
1) In the period January 1 to December 31, 2024, how many times did patients present at your A&E departments (to include major A&E departments and minor injuries units) with dental health problems? If you have any specialist facilities for dental treatment, please exclude these. Of these patients: 2) Can the numbers please be broken down by type of problem e.g. toothache, abscess/infection, loss of teeth, broken or loose teeth, gum disease/bleeding from the mouth, decay. 3) Please can you provide for the following calendar years 2023, 2022, 2021, 2020, how many times did patients present at your A&E departments (to include major A&E departments and minor injuries units) with dental health problems?
Date of Response: 29/04/2025
View Response: 9935.pdf
Freedom of Information Request Reference: 9932
Date Received: 02/04/2025
Summary:
Of all referrals made to prescribe medication for erectile dysfunction due to severe distress ; 1 How many referrals were made in 2019 and 2024? 2 In each year how many requests were declined? 3. How much does the service cost NHS Lothian annually?
Date of Response: 01/05/2025
View Response: 9932.pdf
Freedom of Information Request Reference: 9931
Date Received: 02/04/2025
Summary:
Please provide the following: 1. Senior Remuneration A list of the 10 highest remunerated employees, disclosing for each individual: Job title or role (names are not required) Gross annual salary Employer pension contributions Any performance-related bonuses or incentive payments Other remuneration or taxable benefits (e.g. relocation expenses, housing or car allowances) The total cost to the organisation of employing each individual, including all of the above components If these figures are available in published remuneration reports or accounts, please feel free to provide a link or extract those relevant sections. 2. Expenditure Related to Equality, Diversity & Inclusion (EDI) For the same financial year, please provide: The total gross expenditure on EDI-related activity, including (where possible) a breakdown under the following categories: Staff employed primarily or exclusively in EDI roles (including headcount and job titles) External consultancy or training services commissioned in relation to EDI Internal campaigns, events, or communications relating to EDI Memberships or subscriptions to EDI-related organisations or accreditation bodies If a breakdown is not held or collated centrally, an aggregate figure with explanatory context would be appreciated. 3. Ancillary Non-Clinical Organisational Expenditure Please also provide the total expenditure for the financial year on the following categories, where data is available: Staff engagement activities (e.g. away days, retreats, team-building exercises) External public relations, media consultancy, or “reputation management” services Rebranding, including costs associated with new logos, signage, or corporate visual identity updates Aesthetic or non-clinical enhancements to premises (e.g. commissioned artwork, decorative refurbishments) Expenditure related to environmental sustainability or climate strategy (e.g. staff, consultancy, net zero projects) These categories are not presented as value judgments but to understand wider resource allocation practices. If centralised figures are not available, please provide what is reasonably accessible or advise under section 15 of FOISA (“Duty to Advise and Assist”) on how the request might be refined.
Date of Response: 02/05/2025
View Response: 9931.pdf
Freedom of Information Request Reference: 9930
Date Received: 01/04/2025
Summary:
I would like to request the following information: • Any local guidelines or pathways used within your NHS health board to inform clinicians on coeliac disease diagnosis and follow-up care. We are interested in guidance for adults and children seen in any setting. • If your area does not have local guidance/pathways for coeliac disease, please specify which clinical guidelines (e.g. NICE, ESGPHAN, BSG) are recommended to clinicians.
Date of Response: 28/04/2025
View Response: 9930.pdf
Freedom of Information Request Reference: 9928
Date Received: 01/04/2025
Summary:
For the year 2024:- a. How many babies were born in your health board area? b. How many were born by spontaneous vaginal birth/assisted vaginal birth/planned c-section/unplanned c-sections? c. How many pregnancies were induced? d. Of the inductions, how many were for medical reasons/ personal choice/other reason? e. At how many weeks gestation were the inductions carried out? f. How many births were in CMUs / in hospital/ at home?
Date of Response: 29/04/2025
View Response: 9928.pdf
Freedom of Information Request Reference: 9927
Date Received: 01/04/2025
Summary:
I wish to make a Freedom of Information Request for the number of adults currently on the waiting list for psychological treatment.
Date of Response: 25/04/2025
View Response: 9927.pdf
Freedom of Information Request Reference: 9924
Date Received: 31/03/2025
Summary:
1. Does your NHS Trust/Board have an executive board where health research strategy for the hospital/s is set? e.g a Research and Innovation Board or other relevant high-level board. 2. If yes, is there a PPIE (patient public involvement engagement) representative on this board with the specific remit to provide insights into research agenda setting from the perspective of a patient with lived experience of health issues or as a member of the public/community? [I am not referring to the presence of a lay chair]. 3. Is there a PPIE advisory structure (e.g. board, committee, panel) which provides PPIE insights to inform the work of the executive board? (not within individual study groups- I refer to high level feedback into your research strategy meetings). 4. If yes to question 2, 3, 4 or 5, please provide the most recent minutes/agenda with a list of members with designated roles/remits (not names). 5. Are PPIE representatives remunerated? 6. Do you require PPIE representatives to do any training? If yes, please specify e.g NIHR training or in house-training. 7. I realise that some of this information may already be available. However, I was unable to locate it. So, if it is, please provide me with a link to the data.
Date of Response: 30/04/2025
View Response: 9924.pdf
Freedom of Information Request Reference: 9923
Date Received: 31/03/2025
Summary:
Number of patients currently in treatment at the Regional Eating Disorders Unit (REDU) AND: 1. Number of patients over the past 5 years (2020-2025) 2. Number of patients broken down into those identifying as men / women or other over the past five years 3. Number of referrals to the REDU broken down over the past 5 years 4. Number of staff members at the REDU broken down over the past 5 years AND: 5. Staff members broken down in categories: administration, therapists (/ other psychological help), dieticians, medical staff and other Number of patients currently in treatment at the Cullen Centre 1. Number of patients over the past 5 years 2. Number of patients broken down into those identifying as men / women or other over the past five years 3. Number of referrals to the Cullen Centre broken down over the past 5 years 4. Number of staff members at the Cullen Centre broken down over the past 5 years AND: 5. Staff members broken down in categories: administration, therapists (/ other psychological help), dieticians, medical staff and other
Date of Response: 25/04/2025
View Response: 9923.pdf
Freedom of Information Request Reference: 9920
Date Received: 28/03/2025
Summary:
Could you please tell me: • How much do you spend on printing? • How much do you spend on associated services? • Which suppliers have you used in the past 3 years? • How much have you spent with each supplier in the last 3 years (per year)? • How do you decide which supplier to use? • Do you have contracts with suppliers? • How many suppliers have you asked for quotations in the last 6 months?
Date of Response: 09/05/2025
View Response: 9920.pdf
Freedom of Information Request Reference: 9918
Date Received: 27/03/2025
Summary:
1. If your health board has a neurodevelopment pathway where the assessment service is not provided by CAMHS, please provide the number of referrals for neurodevelopmental assessments have been sent to CAHMS and rejected to the appropriate neurodevelopmental pathway for the following financial years: 2023/24, 2022/23, 2021/22, 2020/21, 2019/20. For each of the following questions, please respond with a Microsoft excel file where possible 2. In this health board, please provide the number of children and young people who were on the waiting list for a CAMHS and/or a neurodevelopmental assessment (NDA) at the end of the 2023/24, 2022/23, 2021/22, 2020/21, 2019/20, 2018/19 and 2017/18 financial years. Please break this data down by those waiting 0-4 weeks, 4-8 weeks, 8-12 weeks, 12-16 weeks, 16-20 weeks, 20-24 weeks, 24-28 weeks, 28-32 weeks, 32-36 weeks, 36-40 weeks, 40-44 weeks, 44-48 weeks, 48-52 weeks, 52-78 weeks, 78-104 weeks, 104-156 weeks, and 156 weeks + 3. If possible, can you separate that data out into the following. If not, please explain why. a. In this health board, please provide the number of children and young people who were on the waiting list for a CAHMS services at the end of the 2021/22, 2020/21, 2019/20, 2018/19 and 2017/18 financial years. Please break this data down by those waiting 0-4 weeks, 4-8 weeks, 8-12 weeks, 12-16 weeks, 16-20 weeks, 20-24 weeks, 24-28 weeks, 28-32 weeks, 32-36 weeks, 36-40 weeks, 40-44 weeks, 44-48 weeks, 48-52 weeks, 52-78 weeks, 78-104 weeks, 104-156 weeks, and 156 weeks + b. In this health board, please provide the number of children and young people who were on the waiting list for a neurodevelopmental assessment (NDA) at the end of the 2023/24, 2022/23, 2021/22, 2020/21, 2019/20, 2018/19 and 2017/18 financial years. Please break this data down by those waiting 0-4 weeks, 4-8 weeks, 8-12 weeks, 12-16 weeks, 16-20 weeks, 20-24 weeks, 24-28 weeks, 28-32 weeks, 32-36 weeks, 36-40 weeks, 40-44 weeks, 44-48 weeks, 48-52 weeks, 52-78 weeks, 78-104 weeks, 104-156 weeks, and 156 weeks +
Date of Response: 06/05/2025
View Response: 9918.pdf
Freedom of Information Request Reference: 9915
Date Received: 27/03/2025
Summary:
I would like to request information regarding the Brand and date of Commissioning for the Urodynamic systems at the following Hospitals within the Trust. The Royal Infirmary of Edinburgh Western General Hospital St John’s Hospital Royal Hospital for Children and Young People
Date of Response: 07/05/2025
View Response: 9915.pdf
Freedom of Information Request Reference: 9910
Date Received: 26/03/2025
Summary:
AI Spend/Adoption Please provide a list of the suppliers who provide AI services to the trust for clinical use cases. Please provide a list of the suppliers who provide AI services to the trust for clerical/administrative use cases. Does the trust utilise any AI and/or technology to facilitate patient appointment booking for the trust? If yes please provide details. Who is accountable in the Trust for outpatient appointments?
Date of Response: 09/05/2025
View Response: 9910.pdf
Freedom of Information Request Reference: 9905
Date Received: 25/03/2025
Summary:
Can you please provide the following information under the Freedom of information act: What is the average booked Clinic Utilisation for the mentioned clinical services? What is the average financial cost to the trust for a vacant/DNA’d outpatient clinic appointment slot for the following clinical services? General Surgery Service Urology Service Trauma and Orthopaedic Service Ear Nose and Throat Service Ophthalmology Service Oral Surgery Service Neurosurgical Service Plastic Surgery Service Cardiothoracic Surgery Service General Internal Medicine Service Gastroenterology Service Cardiology Service Dermatology Service Respiratory Medicine Service Neurology Service Rheumatology Service Elderly Medicine Service Gynaecology Service Other - Medical Services Other - Mental Health Services Other - Paediatric Services Other - Surgical Services Other - Other Services Radiology/Imaging Respiratory physiology - Sleep Studies Urodynamics - Pressures & Flows Endoscopy Trust Average What is the unit cost to the trust for sending an appointment letter to patients and which provider does the trust utilise? If a unit/consumption cost is not available, please provide details of the provider and the annual contract value for appointment notification letters.
Date of Response: 09/05/2025
View Response: 9905.pdf
Freedom of Information Request Reference: 9900
Date Received: 24/03/2025
Summary:
1. How many patients presented at your A&E departments with mental ill health (psychiatric, psychological, and/or behavioural disturbances/changes) as the primary issue each year between and including 2019 to 2025? Please include data up to the end of February 2025. 2. How many patients identified in question 1 waited more than 12 hours for transfer to a bed in a mental health unit after a decision to admit? Please provide year by year data between and including 2019 to 2025, and include data up to the end of February 2025. 3. How many incidents of physical violence carried out towards staff by all patients were reported each year between and including 2019 to 2025 in your A+E departments?  Please include data up to the end of February 2025.
Date of Response: 16/05/2025
View Response: 9900.pdf
Freedom of Information Request Reference: 9886
Date Received: 19/03/2025
Summary:
1. The number of referrals from a primary care to secondary care setting for type 2 diabetes every calendar year for the years 2019, 2020, 2021, 2022, 2023, 2024 2. The number of type 2 diabetic diagnoses every calendar year for the years 2019, 2020, 2021, 2022, 2023, 2024 3. The current waiting lists for NHS Scotland for type 2 & type 1 diabetes services- displayed separately.
Date of Response: 25/04/2025
View Response: 9886.pdf
Freedom of Information Request Reference: 9869
Date Received: 14/03/2025
Summary:
Number of procedures (April 2024 – YTD) 1. The overall / total spend on cataract surgery procedures each financial year by year across your Health Board from 2018/19 to 2023/24. Please additionally supply the total spend on cataract surgery procedures across your Health Board for the financial year of 2024/25 if this is presently available. 2. The overall / total number of cataract surgery procedures undertaken each financial year by year across your Health Board from 2018/19 to 2023/24. Please additionally supply the overall / total number of cataract surgery procedures across your Health Board for the financial year of 2024/25 if this is presently available. 3. The overall / total spend on cataract surgery procedures each financial year by year across your Health Board to each NHS Hospital and Private (Independent Sector) Provider from 2018/19 to 2023/24 broken down by individual NHS Hospital and Private Provider. Please additionally supply the total spend on cataract surgery procedures across your Health Board to each NHS Hospital and Private Provider on an individual level for the financial year of 2024/25 if this is presently available. Please specifically specify your answer to Question 3 for the following Private Providers: a) Optical Express b) Spire Healthcare – Shawfair Park Hospital (Edinburgh) c) Ross Hall Hospital (Circle Health Group) (Glasgow) d) Albyn Hospital (Circle Health Group) (Aberdeen) e) Nuffield Edinburgh Hospital (formerly The Edinburgh Clinic – Aspen Group) f) Nuffield Health Glasgow Hospital g) BMI Kings Park Hospital (Circle Health Group) h) Vision Scotland i) Golden Jubilee Hospital, Clydebank, West Dunbartonshire j) Another Private Provider Not Listed 4. The overall / total number of cataract surgery procedures undertaken in each financial year by year across your Health Board by each NHS Hospital and Private (Independent Sector) Provider from 2018/19 to 2023/24 broken down by individual NHS Hospital and Private Provider. Please additionally supply the total number of cataract surgery procedures undertaken by each NHS Hospital and Private Provider across your Health Board by each NHS Hospital and Private Provider on an individual level for the financial year of 2024/25 if this is presently available. Please specifically specify your answer to Question 4 for the following Private Providers: a) Optical Express b) Spire Healthcare – Shawfair Park Hospital (Edinburgh) c) Ross Hall Hospital (Circle Health Group) (Glasgow) d) Albyn Hospital (Circle Health Group) (Aberdeen) e) Nuffield Edinburgh Hospital (formerly The Edinburgh Clinic – Aspen Group) f) Nuffield Health Glasgow Hospital g) BMI Kings Park Hospital (Circle Health Group) h) Vision Scotland i) Golden Jubilee Hospital, Clydebank, West Dunbartonshire j) Another Private Provider Not Listed 5. For the period 1st of April 2024 to YTD, please provide the names of all in NHS Hospital and Private (Independent Sector) Providers that have undertaken Cataract Surgery, YAG capsulotomy procedures, General Ophthalmology outpatient, Oculoplastic services, AMD services & Glaucoma services of any description to the Health Board. 6. Please provide the number of patients on waiting lists for cataract surgery at the Health Board as of: a) 1 January 2019 b) 1 January 2020 c) 1 January 2021 d) 1 January 2022 e) 1 January 2023 f) 1 January 2024 g) 1 January 2025 7. Please provide the number and percentage of patients who were waiting longer than 18 weeks from the date of referral to cataract surgery as of: a) 1 January 2019 b) 1 January 2020 c) 1 January 2021 d) 1 January 2022 e) 1 January 2023 f) 1 January 2024 g) 1 January 2025 8. Please provide the maximum and average wait times of patients on waiting lists for cataract surgery at the Health Board as of: h) 1 January 2019 i) 1 January 2020 j) 1 January 2021 k) 1 January 2022 l) 1 January 2023 m) 1 January 2024 n) 1 January 2025 9. Please provide the number and percentage of NHS funded patients who had Immediate Sequential Bilateral Cataract Surgery at Hospitals and Private Providers (individually and collectively) within your Health Board in each of the following financial years: a) 2019/2020 b) 2020/2021 c) 2021/2022 d) 2022/2023 e) 2023/2024 f) 2024/2025 10. Please provide the minimum, maximum and average number of eyes treated on cataract surgery lists (by session, up to 4 hours) at Hospitals and Private Providers (individually by provider) within your Health Board in each of the following financial years: g) 2019/2020 h) 2020/2021 i) 2021/2022 j) 2022/2023 k) 2023/2024 l) 2024/2025
Date of Response: 14/05/2025
View Response: 9869.pdf
Freedom of Information Request Reference: 9822
Date Received: 04/03/2025
Summary:
1. The total number of jobs in the Trust for the years 2005, 2010, 2015, 2020 and present day. 2. The number of jobs in the Trusts at Bands 7 and above or the years 2005, 2010, 2015, 2020 and present day. 3. The total cost of salary for those in Bands 7 and above (broken down by Band if possible) for the years 2005, 2010, 2015, 2020 and present day.
Date of Response: 16/05/2025
View Response: 9822.pdf
Freedom of Information Request Reference: 9821
Date Received: 04/03/2025
Summary:
Can I request the following information for each financial year from 2019/20 to 2024/25 (most recent): 1. The number of midwifes that have left their post? 2. The number of midwife vacancies advertised? 3. The number of midwifes employed in your health board? 4. The number of midwifes recommended for your workforce need from the government-directed policy use of a workforce planning tool?
Date of Response: 16/05/2025
View Response: 9821.pdf
Freedom of Information Request Reference: 9796
Date Received: 24/01/2025
Summary:
Could you provide the following information for the last six calendar years (2019, 2020, 2021, 2022, 2023 and 2024 [most recent]) and may I request the information be broken down by hospitals. 1. The number of cases of dampness found within clinical spaces. 2. The number of cases of dampness found within patient used areas. 3. The number of patients who had to be moved due to a case of dampness. 4. The number of clinics or services which had to be moved due to a case of dampness.
Date of Response: 13/05/2025
View Response: 9796.pdf
Freedom of Information Request Reference: 9969
Date Received: 09/04/2025
Summary:
Please can I request the below information on the utilisation of Insourcing for the following period 01/01/2025-31/03/2025 • Total spend during the period for Insourcing for the below specialties: • Neurology • Neurophysiology • Dermatology • Gastroenterology • Endoscopy • Cardiology • Respiratory • Orthodontics / Dental • OMFS • ENT • Rheumatology • Gynaecology • Please break the spend down by insourcing company • Please confirm if there was a budget for insourcing for the specialties outlined during the same period • What was the service type relating to the specialties outlined, for example, outpatient, diagnostic or theatres. • Was it a fully managed service or Team provision • Please can you confirm the Frameworks utilised for each specialty • Please confirm any direct awards or mini competitions which are being utilised for each specialty • Total procedures completed by insourcing companies for the specialties outlined during the same period
Date of Response: 30/04/2025
View Response: 9969.pdf
Freedom of Information Request Reference: 9608
Date Received: 13/01/2025
Summary:
I refer to recent media statements from the leader of the Scottish Liberal Democrats reference babies born with various syndromes arising from mother's substance use before and during pregnancy within the agency of NHS Lothian. Mr Cole-Hamilton states he has obtained this 6 (or shorter period) year information from an FOI. I cannot find such an enquiry and response on your public disclosure statements. Can you please send me information from the last six calender years, babies born harmed by substances, the names of the syndromes involved, the substances involved, whether any deaths sadly occurring within a year of birth.
Date of Response: 13/05/2025
View Response: 9608.pdf
Freedom of Information Request Reference: 9826
Date Received: 04/03/2025
Summary:
Q1. Of all patients diagnosed with Hereditary Ataxia (ICD-10 Code G11), how many have a specific diagnosis of Friedreich Ataxia? Q1a. How many Friedreich Ataxia patients have been diagnosed in the last 12 months? Q1b. How many Friedreich Ataxia patients have had an appointment in the last 12 months in the following departments? · Cardiology · Neurology · Neuromuscular · Specialist movement disorders · Any other department Q1c. How many Friedreich Ataxia patients fall within the following age groups? · 0-13 · 14-15 · 16-40 · 40+ Q1d. How many Friedreich Ataxia patients have you discharged in the last 12 months? Q2. Does your Health Board have a specialist movement disorders clinic? · If so, how many patients with a diagnosis of Fredreich Ataxia have visited the clinic in the last 12 months? Q3. Does your Health Board have a specialist Ataxia Clinic, as part of the specialist movement disorders clinic? · If so, how many patients with a diagnosis of Fredreich Ataxia have visited the clinic in the last 12 months? Q4. As the lead centre in Scotland responsible for Friedrich Ataxia Testing (FRDA) as part of the Scottish Strategic Network for Genomic Medicine, how many samples have you received for Friedrich Ataxia testing in the last 12 months?
Date of Response: 25/04/2025
View Response: 9826.pdf
Freedom of Information Request Reference: 9820
Date Received: 04/03/2025
Summary:
It is my understanding that your health board holds data on your maternity wards/units policy, procedures and standards. 1. When was the last time your health board maternity ward/unit was updated or refurbished? 2. Does every birthing suite have an ensuite toilet and shower facility? 3. Does every postnatal suite have an ensuite toilet and shower facility? 4. Does every multi-bed room/bay have an ensuite toilet and shower facility? 5. What is the furthest distance someone must walk to get from their bed to a toilet and shower within the maternity ward?
Date of Response: 07/05/2025
View Response: 9820.pdf
Freedom of Information Request Reference: 9806
Date Received: 28/02/2025
Summary:
For each individual memory assessment service within the area covered by the HB: 1. The service's annual funding for each of the years 2018-2024 inclusive. 2. The source/s of funding for the service for each of the years 2018-2024 inclusive. 3. The total annual number of patients seen by the service for each of the years 2018-2024 inclusive.
Date of Response: 29/04/2025
View Response: 9806.pdf
Freedom of Information Request Reference: 9802
Date Received: 27/01/2025
Summary:
The current waiting time (as of 24 January 2025) for flexible cystoscopy for a patient who is treated as an ‘Urgent suspected of Cancer’ referral. The current waiting time (as of 24 January 2025) for a breast biopsy for a patient who is treated as an ‘Urgent suspected of Cancer’ referral.
Date of Response: 08/05/2025
View Response: 9802.pdf
Freedom of Information Request Reference: 9801
Date Received: 27/01/2025
Summary:
Home Dialysis Energy Reimbursement: 1. Does your health board currently financially reimburse kidney patients for the additional energy costs of having home dialysis? I currently have the following information for your health board and would be grateful if you could confirm if this is correct or not: NHS Lothian Financial reimbursement for the energy costs for home haemodialysis? Financial reimbursement for the energy costs for home APD? 2. Rate of home dialysis energy reimbursement: What is your health board’s current rate of financial reimbursement for: i. Home haemodialysis ii. Home APD 3. How is your health board’s current rate of home dialysis energy reimbursement calculated for: i. Home haemodialysis ii. Home APD 4. Does your health board’s current rate for home dialysis energy reimbursement consider the cost of heating the room/ cabin where home dialysis takes place? 5. How often does your health board review your home dialysis energy reimbursement rate for: i. Home haemodialysis ii. Home APD 6. Is this reimbursement means-tested, or open to all kidney patients on home haemodialysis and home APD? If it is means -tested please state what criteria a patient needs to meet to receive this? 7. How are kidney patients on home dialysis in your health board made aware that they can be reimbursed for the additional energy costs of undertaking dialysis at home? 8. Process of home dialysis energy reimbursement – how and what process do kidney patients on home dialysis have to go through to be reimbursed for these additional energy costs? 9. With regard to the financial reimbursement for energy costs paid to all kidney patients undergoing home dialysis therapies we request: A. i.the total amount your Board has paid to kidney patients for this between 1 January 2024 and 31 December 2024 (total and breakdown by type of home dialysis), and ii. the total number of kidney patients who received these payments within this time period? (total and breakdown by type of home dialysis) B. i.the total amount your Board has paid to kidney patients in the last financial year for this (total and breakdown by type of home dialysis), and ii. the total number of kidney patients who received these payments within this time period? (total and breakdown by type of home dialysis) 10. How many people in your health board are on: I. Home haemodialysis II. Home APD III. Home CAPD
Date of Response: 25/04/2025
View Response: 9801.pdf
Freedom of Information Request Reference: 9790
Date Received: 26/02/2025
Summary:
I wish to make the following information request, under The Freedom of Information (Scotland) Act 2002, regarding the legal obligations and day-to-day operational requirements for medical and nursing staff when recording information in patient medical records: 1. **Legal Requirements**: a. Please provide a detailed explanation of the statutory, regulatory and professional obligations (e.g., under the Data Protection Act 2018, UK GDPR, GMC/NMC guidelines, or NHS policies) that govern how medical and nursing staff must document patient interactions, treatments, and decisions in medical records. b. Any specific legal consequences for non-compliance with these requirements. 2. **Operational Guidance**: a. The NHS’s internal policies or guidelines provided to medical and nursing staff on the content, format, and timeliness of entries in medical records (e.g. minimum information required, use of electronic vs. paper systems and deadlines for completing entries). b. Whether there are differences in requirements for medical staff (e.g., doctors versus nursing staff etc. 3. **Training and Compliance**: a. Details of any mandatory training provided to medical and nursing staff on record-keeping standards. b. How compliance with these requirements is monitored or audited. 4. **Supplementary Documents**: a. Copies of relevant policies, procedural documents, or training materials referenced in the above responses.
Date of Response: 25/04/2025
View Response: 9790.pdf
Freedom of Information Request Reference: 9767
Date Received: 30/01/2025
Summary:
Q1. For patients treated by the dermatology department with Dupilumab in the latest four months (September to December 2024), could you please tell us: a. how many patients were treated in the previous 4-month period (May to August 2024) with Dupilumab? b. how many patients were treated in the previous 4-month period (May to August 2024) with any of the following advanced therapies: abrocitinib, baricitinib, tralokinumab, upadacitinib and lebrikizumab? c. how many patients were treated in the previous 4-month period (May to August 2024) with any of the following immunosuppressants: Methotrexate, Ciclosporin, Mycophenolate or Azathioprine? d. how many patients were treated in the previous 4-month period (May to August 2024) with any other treatment? (e.g. Acitretin, Alitretoin, Pimecrolimus, Tacrolimus, oral corticosteroids , topical steroids) Q2. For patients treated by the dermatology department with Dupilumab in the four months from May to August 2024, could you please let us: a. how many patients were treated in the subsequent 4-month period (September to December 2024) with Dupilumab? b. how many patients were treated in the subsequent 4-month period (September to December 2024) with any of the following advanced therapies: abrocitinib, baricitinib, tralokinumab, upadacitinib and lebrikizumab? c. how many patients were treated in the subsequent 4-month period (September to December 2024) with any of the following immunosuppressants: Methotrexate, Ciclosporin, Mycophenolate or Azathioprine? d. how many patients were treated in the subsequent 4-month period (September to December 2024) with any other treatment? (e.g. Acitretin, Alitretoin, Pimecrolimus, Tacrolimus, oral corticosteroids , topical steroids)
Date of Response: 06/03/2025
View Response: 9767.pdf
Freedom of Information Request Reference: 9692
Date Received: 31/01/2025
Summary:
Are you able to tell me how many babies diagnosed with truncus arteriosus ( both with and without an interrupted aortic arch) were transferred to Glasgow from Lothian, for delivery, or soon after delivery for treatment, from January 2019 to date?
Date of Response: 07/05/2025
View Response: 9692.pdf
Carer Positive Icon
Awards Aware Icon
We are a Living wage Employer Icon
Duke of Edinburgh's Award Logo
Young Person's Guaranteed Employer Logo
Scottish Top Employers Logo
Disability Confident Employer Logo
 
CONTACT NHS LOTHIAN
Lothian NHS Board
Mainpoint
102 Westport
Edinburgh
EH3 9DN

Main Switchboard: 0131 242 1000
YOUR RIGHTS
OUR VALUES INTO ACTION
Around 3,000 colleagues across NHS Lothian have developed Our Values, a set of common values and ways of working - to the benefit of everyone working in the organisation and, most importantly - to the benefit of our patients.
WORKING WITH NHS LOTHIAN
MEDIA ENQUIRIES
STAY CONNECTED TO NHS LOTHIAN
Facebook
Twitter
YouTube
Vimeo
Instagram
PARTNERS